Literature DB >> 7927411

Is there a role for interleukin-1 blockade in intravenous immunoglobulin therapy?

C A Dinarello1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7927411     DOI： 10.1111/j.1600-065x.1994.tb00862.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN： 0105-2896            Impact factor:   12.988


× No keyword cloud information.
  4 in total

1.  Variability of the inhibition by total immunoglobulin of in vitro autoantibody-mediated erythrophagocytosis by mouse macrophages.

Authors:  S Léonard; I Pierard; T E Michaelsen; S Izui; P L Masson; J-P Coutelier
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 2.  Immunity, infection, and nasal disease.

Authors:  S H Yoshida; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  1998 Spring-Summer       Impact factor: 8.667

3.  Cytomegalovirus immune globulin intravenous (human) administration modulates immune response to alloantigens in sensitized renal transplant candidates.

Authors:  K S Sivasai; T Mohanakumar; D Phelan; S Martin; M E Anstey; D C Brennan
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

4.  Modulation of alloimmune response in vitro by an IgM-enriched immunoglobulin preparation (Pentaglobin).

Authors:  D Nachbaur; M Herold; A Gächter; D Niederwieser
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.